MidCap Financial Investment Corporation (MFIC) Q4 2025 Earnings Call Transcript — Neutral
MFIC Seeking Alpha — February 27, 2026MidCap Financial Investment Corporation (MFIC) Q4 2025 Earnings Call Transcript
Enrollment Opens for K12-Powered Virtual Public Schools Serving Students Across Ohio — Neutral
LRN GlobeNewsWire — February 27, 2026Ohio Families Can Enroll in Full-Time, K12-Powered Virtual Public School Programs Led by State-Certified Teachers Ohio Families Can Enroll in Full-Time, K12-Powered Virtual Public School Programs Led by State-Certified Teachers
Enrollment Opens for K12-Powered Virtual Public Schools Serving Students Across Missouri — Neutral
LRN GlobeNewsWire — February 27, 2026Missouri Families Can Enroll in Full-Time, K12-Powered Virtual Public School Programs Led by State-Certified Teachers Missouri Families Can Enroll in Full-Time, K12-Powered Virtual Public School Programs Led by State-Certified Teachers
VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit — Neutral
VTGN PRNewsWire — February 27, 2026NEW YORK, Feb. 27, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Vistagen Therapeutics, Inc. (NASDAQ: VTGN) between April 1, 2024 and December 16, 2025, both dates inclusive (the "Class Period"), of the important March 16, 2026 lead plaintiff deadline. So what: If you purchased Vistagen common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Sabra Health Care: Leveraging SHOP To Capture Silver Tsunami Tailwinds — Positive
SBRA SIL SILJ SIVR SLV SLVP Seeking Alpha — February 27, 2026Sabra Health Care remains a Buy, supported by strong SHOP expansion, robust guidance, and a sustainable 5.84% dividend yield. SBRA projects 4.9%-5.4% FFO growth and plans over $450 million in investments for 2026, with a solid pipeline and a good debt schedule. Leverage is steady at 5x, with recent refinancing extending maturities and reducing interest costs, supporting financial flexibility.
‘As the world breaks up, you're going to need a monetary reserve system' – Sprott's Paul Wong on why Bretton Woods III is inevitable and gold stands alone — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — February 27, 2026Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
INVESTOR ALERT: Investigation of Eos Energy Enterprises, Inc. (EOSE) announced by Holzer & Holzer, LLC — Neutral
EOSE GlobeNewsWire — February 27, 2026ATLANTA, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Eos Energy Enterprises, Inc. (“Eos Energy” or the “Company”) (NASDAQ: EOSE) complied with federal securities laws. On February 26, 2026, Eos Energy announced its fourth quarter and full year 2025 results, reporting a “[n]et loss attributable to shareholders of $969.6 million, driven primarily by $746.8 million or 77% non-cash items related to fair value accounting, capital structure optimization, and other items such as stock-based compensation and depreciation.” The price of the Company's stock dropped following this news.
Defense Spending Outlook Could Propel This Thrilling ETF — Positive
DFEN ETF Trends — February 27, 2026Aerospace and defense stocks have been displaying leadership for awhile now. They derive significant benefit from global governments pledging to allocate more capital to national security.
US agency approves Charter Communications' $34.5 billion deal to buy Cox — Positive
CHTR Reuters — February 27, 2026The Federal Communications Commission said Friday it approved Charter Communications' $34.5 billion acquisition of Cox Communications.
Match Group: A Re-Rating Setup Backed By Double-Digit Yield (Rating Upgrade) — Positive
MTCH Seeking Alpha — February 27, 2026Match Group is upgraded to Strong Buy as valuation is compelling even under conservative assumptions, with robust cash flow and yield. MTCH reported strong Q4 results, guided for $1.11B FCF in 2026, and trades at a ~7.14 P/FCF ratio based on 2025's numbers, supporting aggressive capital returns. Tinder's turnaround, Hinge's strong growth, and disciplined reinvestment of cost savings are key catalysts, despite near-term macro and competitive headwinds.
Gold prices push back above $5,200; sees solid rebound in February to end month with another record — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — February 27, 2026Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.
Cinemark Holdings, Inc. is facing persistent long-term industry headwinds despite potential for near-term box office upside. Unusually, I am more optimistic than industry estimates; thanks to Spider-Man and Avengers, the 2026 box office might just push above $10 billion for the first time since COVID. Concessions revenue now exceeds 80% of admissions, but rising film rental costs and G&A expenses pressured CNK's 2025 operating income.
Should Investors Worry About ExxonMobil if Oil Prices Slip in 2026? — Negative
XOM Zacks Investment Research — February 27, 2026According to data from OilPrice.com, the price of West Texas Intermediate (WTI) crude is trading above $65 per barrel, which is favorable for the upstream operations of Exxon Mobil Corporation XOM. However, the U.S. Energy Information Administration (“EIA”) projects the spot average WTI price for 2026 at $53.42 per barrel, lower than $65.40 for 2025, owing to rising oil inventories.
Palantir's stock nabs another upgrade, with its valuation now less of a ‘struggle' — Positive
PLTR Market Watch — February 27, 2026Palantir Technologies' stock has been a fan favorite among retail investors. Now, Wall Street analysts are warming to the software company's story.
The real winner in the battle for Warner Bros. isn't who you think it is — Neutral
WBD Market Watch — February 27, 2026Also in Weekend Reads: How to invest during the AI transition, what OpenAI needs to do and a warning for aspiring day traders.
Periodic consolidation and correction aside, the uptrend in The TJX Companies NYSE: TJX is positioned to continue. This is because the company continues to grow, is well-positioned in the retail market, and has a strong track record of capital returns.
EOSE Stock Alert: Eos Energy Securities Fraud Investigation Focuses on Results and Manufacturing Issues; Investors with Losses Notified to Contact BFA Law — Neutral
EOSE GlobeNewsWire — February 27, 2026NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Eos Energy Enterprises, Inc. (NASDAQ:EOSE) for potential violations of the federal securities laws. If you invested in Eos, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/eos-energy-class-action-lawsuit.
CNBC's Jim Cramer on why Corning and Qnity are 'pleasant surprises' — Positive
GLW Q CNBC Television — February 27, 2026CNBC's Jim Cramer discusses two stocks he says are “pleasant surprises,” Corning and Qnity, during the Investing Club Monthly Meeting on Friday.
Teledyne and M Subs Announce Strategic Collaboration — Neutral
TDY Business Wire — February 27, 2026NORTH FALMOUTH, Mass.--(BUSINESS WIRE)--Teledyne Marine, a global leader in maritime unmanned underwater vehicles and marine technologies, and M Subs, a UK-based innovator in marine unmanned systems and associated autonomy, are pleased to announce the signing of a Memorandum of Understanding (MOU) to establish a strategic collaboration. This partnership aims to leverage the complementary expertise of both organizations to develop and execute business opportunities related to the UK Royal Navy a.
Day One Biopharmaceuticals: Commercial Performance With Catalysts Ahead — Positive
DAWN Seeking Alpha — February 27, 2026Day One Biopharmaceuticals, Inc.'s Q4 '25 came with net product revenues of $52.8M, up 36% from the prior quarter. DAWN's 2026 guidance for U.S. net product revenues of $225M-$250M implies 50% growth over 2025 at the midpoint of that guidance. Key catalysts include clinical readouts from Emi-Le and DAY-301 in 2026. A readout from FIREFLY-2 could come in mid-2027.